Symbol:
Slc2a6
Name:
solute carrier family 2 member 6
RGD ID:
1309317
Description:
Predicted to be involved in regulation of glycolytic process. Predicted to be located in lysosomal membrane. Orthologous to human SLC2A6 (solute carrier family 2 member 6); INTERACTS WITH 17beta-estradiol; 17beta-estradiol 3-benzoate; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LOC296600; solute carrier family 2 (facilitated glucose transporter), member 6; solute carrier family 2, facilitated glucose transporter member 6
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 3 30,746,472 - 30,753,287 (-) NCBI GRCr8 mRatBN7.2 3 10,348,395 - 10,355,208 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 3 10,348,395 - 10,355,208 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 3 13,408,411 - 13,415,225 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 3 21,993,812 - 22,000,626 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 3 20,249,113 - 20,255,927 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 3 5,567,729 - 5,575,144 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 3 5,568,321 - 5,575,136 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 3 10,930,061 - 10,936,876 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 3 5,917,992 - 5,924,807 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 3 5,918,815 - 5,925,027 (-) NCBI Celera 3 5,146,427 - 5,153,242 (-) NCBI Celera Cytogenetic Map 3 p12 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Slc2a6 Rat (-)-epigallocatechin 3-gallate increases expression ISO SLC2A6 (Homo sapiens) 6480464 epigallocatechin gallate results in increased expression of SLC2A6 mRNA CTD PMID:32512070 Slc2a6 Rat 1,2-dichloroethane increases expression ISO Slc2a6 (Mus musculus) 6480464 ethylene dichloride results in increased expression of SLC2A6 mRNA CTD PMID:28960355 Slc2a6 Rat 1,2-dimethylhydrazine multiple interactions ISO Slc2a6 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC2A6 mRNA CTD PMID:22206623 Slc2a6 Rat 17beta-estradiol multiple interactions ISO SLC2A6 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of SLC2A6 mRNA CTD PMID:30165855 Slc2a6 Rat 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC2A6 mRNA CTD PMID:32741896 Slc2a6 Rat 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC2A6 mRNA CTD PMID:32741896 Slc2a6 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC2A6 mRNA CTD PMID:22298810 Slc2a6 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC2A6 mRNA CTD PMID:33387578 Slc2a6 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Slc2a6 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC2A6 mRNA CTD PMID:19933214 and PMID:26290441 Slc2a6 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc2a6 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC2A6 mRNA CTD PMID:21570461 and PMID:26377647 Slc2a6 Rat 2-amino-2-deoxy-D-glucopyranose decreases expression ISO Slc2a6 (Mus musculus) 6480464 Glucosamine results in decreased expression of SLC2A6 mRNA CTD PMID:17178593 Slc2a6 Rat 2-palmitoylglycerol increases expression ISO SLC2A6 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of SLC2A6 mRNA CTD PMID:37199045 Slc2a6 Rat 4,4'-sulfonyldiphenol increases methylation ISO Slc2a6 (Mus musculus) 6480464 bisphenol S results in increased methylation of SLC2A6 exon CTD PMID:33297965 Slc2a6 Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of SLC2A6 mRNA CTD PMID:31881176 Slc2a6 Rat acrylamide decreases expression ISO SLC2A6 (Homo sapiens) 6480464 Acrylamide results in decreased expression of SLC2A6 mRNA CTD PMID:32763439 Slc2a6 Rat aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of SLC2A6 mRNA CTD PMID:33354967 Slc2a6 Rat aldehydo-D-glucosamine decreases expression ISO Slc2a6 (Mus musculus) 6480464 Glucosamine results in decreased expression of SLC2A6 mRNA CTD PMID:17178593 Slc2a6 Rat aldehydo-D-glucose decreases expression ISO Slc2a6 (Mus musculus) 6480464 Glucose results in decreased expression of SLC2A6 mRNA CTD PMID:17178593 Slc2a6 Rat alpha-Zearalanol increases expression EXP 6480464 Zeranol results in increased expression of SLC2A6 mRNA CTD PMID:35163327 Slc2a6 Rat antimycin A decreases expression ISO SLC2A6 (Homo sapiens) 6480464 Antimycin A results in decreased expression of SLC2A6 mRNA CTD PMID:33512557 Slc2a6 Rat antirheumatic drug decreases expression ISO SLC2A6 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of SLC2A6 mRNA CTD PMID:24449571 Slc2a6 Rat aristolochic acid A decreases expression ISO SLC2A6 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of SLC2A6 mRNA CTD PMID:33212167 Slc2a6 Rat atrazine decreases expression ISO SLC2A6 (Homo sapiens) 6480464 Atrazine results in decreased expression of SLC2A6 mRNA CTD PMID:22378314 Slc2a6 Rat benzene affects expression ISO SLC2A6 (Homo sapiens) 6480464 Benzene affects the expression of SLC2A6 mRNA CTD PMID:21147609 Slc2a6 Rat benzo[a]pyrene multiple interactions ISO Slc2a6 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC2A6 mRNA CTD PMID:27858113 Slc2a6 Rat benzo[b]fluoranthene increases expression ISO Slc2a6 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of SLC2A6 mRNA CTD PMID:26377693 Slc2a6 Rat benzo[b]fluoranthene multiple interactions ISO Slc2a6 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC2A6 mRNA CTD PMID:27858113 Slc2a6 Rat Benzo[k]fluoranthene increases expression ISO Slc2a6 (Mus musculus) 6480464 benzo(k)fluoranthene results in increased expression of SLC2A6 mRNA CTD PMID:26377693 Slc2a6 Rat beta-D-glucosamine decreases expression ISO Slc2a6 (Mus musculus) 6480464 Glucosamine results in decreased expression of SLC2A6 mRNA CTD PMID:17178593 Slc2a6 Rat beta-lapachone decreases expression ISO SLC2A6 (Homo sapiens) 6480464 beta-lapachone results in decreased expression of SLC2A6 mRNA CTD PMID:38218311 Slc2a6 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC2A6 mRNA CTD PMID:25181051 Slc2a6 Rat buta-1,3-diene decreases expression ISO Slc2a6 (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of SLC2A6 mRNA CTD PMID:29038090 Slc2a6 Rat butanal increases expression ISO SLC2A6 (Homo sapiens) 6480464 butyraldehyde results in increased expression of SLC2A6 mRNA CTD PMID:26079696 Slc2a6 Rat caffeine affects phosphorylation ISO SLC2A6 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of SLC2A6 protein CTD PMID:35688186 Slc2a6 Rat cannabidiol increases expression ISO Slc2a6 (Mus musculus) 6480464 Cannabidiol results in increased expression of SLC2A6 mRNA CTD PMID:21542829 Slc2a6 Rat carbon nanotube increases expression ISO Slc2a6 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 Slc2a6 Rat choline multiple interactions ISO Slc2a6 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC2A6 gene CTD PMID:20938992 Slc2a6 Rat chrysene multiple interactions ISO Slc2a6 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC2A6 mRNA CTD PMID:27858113 Slc2a6 Rat cisplatin increases expression ISO SLC2A6 (Homo sapiens) 6480464 Cisplatin results in increased expression of SLC2A6 mRNA CTD PMID:27594783 Slc2a6 Rat cisplatin multiple interactions ISO SLC2A6 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SLC2A6 mRNA CTD PMID:27392435 Slc2a6 Rat cyclophosphamide increases expression ISO SLC2A6 (Homo sapiens) 6480464 Cyclophosphamide results in increased expression of SLC2A6 mRNA CTD PMID:21527772 Slc2a6 Rat cyclosporin A increases expression ISO SLC2A6 (Homo sapiens) 6480464 Cyclosporine results in increased expression of SLC2A6 mRNA CTD PMID:20106945 Slc2a6 Rat cyclosporin A decreases expression ISO SLC2A6 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SLC2A6 mRNA CTD PMID:25562108 Slc2a6 Rat D-glucose decreases expression ISO Slc2a6 (Mus musculus) 6480464 Glucose results in decreased expression of SLC2A6 mRNA CTD PMID:17178593 Slc2a6 Rat DDE decreases expression ISO SLC2A6 (Homo sapiens) 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC2A6 mRNA CTD PMID:38568856 Slc2a6 Rat deguelin decreases expression ISO SLC2A6 (Homo sapiens) 6480464 deguelin results in decreased expression of SLC2A6 mRNA CTD PMID:33512557 Slc2a6 Rat dexamethasone decreases expression ISO Slc2a6 (Mus musculus) 6480464 Dexamethasone results in decreased expression of SLC2A6 mRNA CTD PMID:22733784 Slc2a6 Rat dexamethasone increases expression ISO SLC2A6 (Homo sapiens) 6480464 Dexamethasone results in increased expression of SLC2A6 mRNA CTD PMID:25047013 Slc2a6 Rat dimethyl sulfoxide affects expression ISO SLC2A6 (Homo sapiens) 6480464 Dimethyl Sulfoxide affects the expression of SLC2A6 mRNA CTD PMID:24834073 Slc2a6 Rat doxorubicin decreases expression ISO SLC2A6 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of SLC2A6 mRNA CTD PMID:29803840 Slc2a6 Rat ethanol increases expression ISO Slc2a6 (Mus musculus) 6480464 Ethanol results in increased expression of SLC2A6 mRNA CTD PMID:19167417 Slc2a6 Rat ethanol affects expression ISO Slc2a6 (Mus musculus) 6480464 Ethanol affects the expression of SLC2A6 mRNA CTD PMID:30319688 Slc2a6 Rat etoposide increases expression ISO SLC2A6 (Homo sapiens) 6480464 Etoposide results in increased expression of SLC2A6 mRNA CTD PMID:21527772 Slc2a6 Rat folic acid multiple interactions ISO Slc2a6 (Mus musculus) 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 Slc2a6 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SLC2A6 mRNA CTD PMID:33387578 Slc2a6 Rat glucose decreases expression ISO Slc2a6 (Mus musculus) 6480464 Glucose results in decreased expression of SLC2A6 mRNA CTD PMID:17178593 Slc2a6 Rat ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of SLC2A6 mRNA CTD PMID:20080153 Slc2a6 Rat L-methionine multiple interactions ISO Slc2a6 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC2A6 gene CTD PMID:20938992 Slc2a6 Rat lipopolysaccharide increases expression ISO SLC2A6 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of SLC2A6 mRNA CTD PMID:35811015 Slc2a6 Rat lipopolysaccharide multiple interactions ISO SLC2A6 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 Slc2a6 Rat methyl methanesulfonate increases expression ISO SLC2A6 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of SLC2A6 mRNA CTD PMID:21527772 Slc2a6 Rat nickel atom increases expression ISO SLC2A6 (Homo sapiens) 6480464 Nickel results in increased expression of SLC2A6 mRNA CTD PMID:25583101 Slc2a6 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLC2A6 mRNA CTD PMID:25729387 Slc2a6 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC2A6 mRNA CTD PMID:33387578 Slc2a6 Rat pentanal increases expression ISO SLC2A6 (Homo sapiens) 6480464 pentanal results in increased expression of SLC2A6 mRNA CTD PMID:26079696 Slc2a6 Rat picoxystrobin decreases expression ISO SLC2A6 (Homo sapiens) 6480464 picoxystrobin results in decreased expression of SLC2A6 mRNA CTD PMID:33512557 Slc2a6 Rat pioglitazone multiple interactions ISO Slc2a6 (Mus musculus) 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of SLC2A6 mRNA CTD PMID:27935865 Slc2a6 Rat propanal increases expression ISO SLC2A6 (Homo sapiens) 6480464 propionaldehyde results in increased expression of SLC2A6 mRNA CTD PMID:26079696 Slc2a6 Rat pyrimidifen decreases expression ISO SLC2A6 (Homo sapiens) 6480464 pyrimidifen results in decreased expression of SLC2A6 mRNA CTD PMID:33512557 Slc2a6 Rat rotenone decreases expression ISO SLC2A6 (Homo sapiens) 6480464 Rotenone results in decreased expression of SLC2A6 mRNA CTD PMID:33512557 Slc2a6 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO SLC2A6 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 Slc2a6 Rat silicon dioxide increases expression ISO Slc2a6 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of SLC2A6 mRNA CTD PMID:23221170 and PMID:29341224 Slc2a6 Rat sunitinib increases expression ISO SLC2A6 (Homo sapiens) 6480464 Sunitinib results in increased expression of SLC2A6 mRNA CTD PMID:31533062 Slc2a6 Rat tebufenpyrad decreases expression ISO SLC2A6 (Homo sapiens) 6480464 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of SLC2A6 mRNA CTD PMID:33512557 Slc2a6 Rat temozolomide increases expression ISO SLC2A6 (Homo sapiens) 6480464 Temozolomide results in increased expression of SLC2A6 mRNA CTD PMID:31758290 Slc2a6 Rat testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC2A6 mRNA CTD PMID:32741896 Slc2a6 Rat tetraphene multiple interactions ISO Slc2a6 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC2A6 mRNA CTD PMID:27858113 Slc2a6 Rat thapsigargin decreases expression ISO SLC2A6 (Homo sapiens) 6480464 Thapsigargin results in decreased expression of SLC2A6 mRNA CTD PMID:22378314 Slc2a6 Rat thifluzamide decreases expression ISO SLC2A6 (Homo sapiens) 6480464 thifluzamide results in decreased expression of SLC2A6 mRNA CTD PMID:33512557 Slc2a6 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SLC2A6 mRNA CTD PMID:23411599 and PMID:34492290 Slc2a6 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLC2A6 mRNA CTD PMID:25729387 Slc2a6 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLC2A6 mRNA CTD PMID:33387578 Slc2a6 Rat tunicamycin decreases expression ISO SLC2A6 (Homo sapiens) 6480464 Tunicamycin results in decreased expression of SLC2A6 mRNA CTD PMID:22378314 Slc2a6 Rat urethane decreases expression ISO SLC2A6 (Homo sapiens) 6480464 Urethane results in decreased expression of SLC2A6 mRNA CTD PMID:28818685 Slc2a6 Rat valproic acid decreases expression ISO SLC2A6 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of SLC2A6 mRNA CTD PMID:29154799 Slc2a6 Rat valproic acid increases methylation ISO SLC2A6 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of SLC2A6 gene CTD PMID:29154799 Slc2a6 Rat valproic acid increases expression ISO SLC2A6 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLC2A6 mRNA CTD PMID:23179753 Slc2a6 Rat zidovudine increases expression ISO SLC2A6 (Homo sapiens) 6480464 Zidovudine results in increased expression of SLC2A6 mRNA CTD PMID:24292225
(-)-epigallocatechin 3-gallate (ISO) 1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (ISO) 17beta-estradiol (EXP,ISO) 17beta-estradiol 3-benzoate (EXP) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2-amino-2-deoxy-D-glucopyranose (ISO) 2-palmitoylglycerol (ISO) 4,4'-sulfonyldiphenol (ISO) acetamide (EXP) acrylamide (ISO) aflatoxin B1 (EXP) aldehydo-D-glucosamine (ISO) aldehydo-D-glucose (ISO) alpha-Zearalanol (EXP) antimycin A (ISO) antirheumatic drug (ISO) aristolochic acid A (ISO) atrazine (ISO) benzene (ISO) benzo[a]pyrene (ISO) benzo[b]fluoranthene (ISO) Benzo[k]fluoranthene (ISO) beta-D-glucosamine (ISO) beta-lapachone (ISO) bisphenol A (EXP) buta-1,3-diene (ISO) butanal (ISO) caffeine (ISO) cannabidiol (ISO) carbon nanotube (ISO) choline (ISO) chrysene (ISO) cisplatin (ISO) cyclophosphamide (ISO) cyclosporin A (ISO) D-glucose (ISO) DDE (ISO) deguelin (ISO) dexamethasone (ISO) dimethyl sulfoxide (ISO) doxorubicin (ISO) ethanol (ISO) etoposide (ISO) folic acid (ISO) gentamycin (EXP) glucose (ISO) ketamine (EXP) L-methionine (ISO) lipopolysaccharide (ISO) methyl methanesulfonate (ISO) nickel atom (ISO) oxaliplatin (EXP) paracetamol (EXP) pentanal (ISO) picoxystrobin (ISO) pioglitazone (ISO) propanal (ISO) pyrimidifen (ISO) rotenone (ISO) S-(1,2-dichlorovinyl)-L-cysteine (ISO) silicon dioxide (ISO) sunitinib (ISO) tebufenpyrad (ISO) temozolomide (ISO) testosterone (EXP) tetraphene (ISO) thapsigargin (ISO) thifluzamide (ISO) thioacetamide (EXP) topotecan (EXP) trichloroethene (EXP) tunicamycin (ISO) urethane (ISO) valproic acid (ISO) zidovudine (ISO)
Slc2a6 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 3 30,746,472 - 30,753,287 (-) NCBI GRCr8 mRatBN7.2 3 10,348,395 - 10,355,208 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 3 10,348,395 - 10,355,208 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 3 13,408,411 - 13,415,225 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 3 21,993,812 - 22,000,626 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 3 20,249,113 - 20,255,927 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 3 5,567,729 - 5,575,144 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 3 5,568,321 - 5,575,136 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 3 10,930,061 - 10,936,876 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 3 5,917,992 - 5,924,807 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 3 5,918,815 - 5,925,027 (-) NCBI Celera 3 5,146,427 - 5,153,242 (-) NCBI Celera Cytogenetic Map 3 p12 NCBI
SLC2A6 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 9 133,471,094 - 133,479,099 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 9 133,471,094 - 133,479,127 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 9 136,336,216 - 136,344,221 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 9 135,326,038 - 135,334,039 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 9 133,365,773 - 133,373,772 NCBI Celera 9 106,886,840 - 106,894,900 (-) NCBI Celera Cytogenetic Map 9 q34.2 NCBI HuRef 9 105,837,905 - 105,845,965 (-) NCBI HuRef CHM1_1 9 136,486,719 - 136,494,779 (-) NCBI CHM1_1 T2T-CHM13v2.0 9 145,685,501 - 145,693,506 (-) NCBI T2T-CHM13v2.0
Slc2a6 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 2 26,911,375 - 26,918,011 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 2 26,911,375 - 26,918,010 (-) Ensembl GRCm39 Ensembl GRCm38 2 27,021,363 - 27,028,000 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 2 27,021,363 - 27,027,998 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 2 26,876,885 - 26,883,518 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 2 26,843,377 - 26,849,999 (-) NCBI MGSCv36 mm8 Celera 2 26,724,006 - 26,730,639 (-) NCBI Celera Cytogenetic Map 2 A3 NCBI cM Map 2 19.18 NCBI
Slc2a6 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955513 2,796,531 - 2,802,054 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955513 2,796,086 - 2,802,051 (-) NCBI ChiLan1.0 ChiLan1.0
SLC2A6 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 11 5,873,830 - 5,887,386 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 9 5,876,165 - 5,890,316 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 9 104,589,227 - 104,602,769 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 9 133,205,995 - 133,214,051 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 9 133,205,995 - 133,214,051 (-) Ensembl panpan1.1 panPan2
SLC2A6 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 9 49,878,325 - 49,885,549 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 9 49,878,634 - 49,885,696 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 9 49,159,453 - 49,166,663 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 9 50,752,218 - 50,759,412 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 9 50,752,220 - 50,759,454 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 9 49,514,270 - 49,521,477 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 9 49,856,019 - 49,863,218 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 9 49,934,179 - 49,941,399 (-) NCBI UU_Cfam_GSD_1.0
Slc2a6 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024404947 199,936,195 - 199,942,864 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936669 3,432,188 - 3,442,531 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936669 3,432,206 - 3,438,849 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
SLC2A6 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 1 273,063,270 - 273,075,391 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 1 273,063,261 - 273,075,455 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 1 307,041,084 - 307,049,223 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
SLC2A6 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 12 4,649,140 - 4,665,609 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 12 4,657,613 - 4,664,669 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666058 323,626 - 331,923 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Slc2a6 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 248 Count of miRNA genes: 168 Interacting mature miRNAs: 190 Transcripts: ENSRNOT00000008034 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1358357 Srcrtb1 Stress Responsive Cort Basal QTL 1 6.36 0.002 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 3 8658162 27494778 Rat 4889966 Bss95 Bone structure and strength QTL 95 4.4 tibia area (VT:1000281) tibia-fibula cross-sectional area (CMO:0001718) 3 1 36847613 Rat 2292615 Ept17 Estrogen-induced pituitary tumorigenesis QTL 17 6.7 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 3 6537645 10778823 Rat 10401810 Kidm53 Kidney mass QTL 53 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 3 8227194 47233430 Rat 1298526 Arunc3 Aerobic running capacity QTL 3 2.2 exercise endurance trait (VT:0002332) maximum distance run on treadmill (CMO:0001406) 3 8227194 33703538 Rat 631545 Bp85 Blood pressure QTL 85 3.1 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 3 1 33278763 Rat 631679 Cm10 Cardiac mass QTL 10 7.34 0.0001 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 3 1 31158234 Rat 2290452 Scl56 Serum cholesterol level QTL 56 2.26 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 3 1 91609953 Rat 631568 Bp92 Blood pressure QTL 92 2.2 0.005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 3 1 39874793 Rat 70203 Gcr2 Gastric cancer resistance QTL 2 2.6 stomach morphology trait (VT:0000470) stomach tumor susceptibility score (CMO:0002043) 3 8658162 27494778 Rat 70202 Alc19 Alcohol consumption QTL 19 2.5 drinking behavior trait (VT:0001422) ethanol intake volume to total fluid intake volume ratio (CMO:0001591) 3 1 27494778 Rat 2312664 Scl62 Serum cholesterol level QTL 62 0.05 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 3 1 38710544 Rat 61468 Bp15 Blood pressure QTL 15 4.4 blood pressure trait (VT:0000183) pulse pressure (CMO:0000292) 3 1 33278763 Rat 1358185 Ept6 Estrogen-induced pituitary tumorigenesis QTL 6 6.7 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 3 6537645 10778823 Rat 631831 Alc8 Alcohol consumption QTL 8 2.7 consumption behavior trait (VT:0002069) calculated ethanol drink intake rate (CMO:0001615) 3 1 33230976 Rat
RH139471
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 3 10,348,500 - 10,348,687 (+) MAPPER mRatBN7.2 Rnor_6.0 3 5,568,427 - 5,568,613 NCBI Rnor6.0 Rnor_5.0 3 10,930,167 - 10,930,353 UniSTS Rnor5.0 RGSC_v3.4 3 5,918,098 - 5,918,284 UniSTS RGSC3.4 Celera 3 5,146,533 - 5,146,719 UniSTS RH 3.4 Map 3 21.9 UniSTS Cytogenetic Map 3 p12 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000008034 ⟹ ENSRNOP00000008034
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 3 10,348,395 - 10,355,208 (-) Ensembl Rnor_6.0 Ensembl 3 5,568,321 - 5,575,136 (-) Ensembl
RefSeq Acc Id:
NM_001106562 ⟹ NP_001100032
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 30,746,472 - 30,753,287 (-) NCBI mRatBN7.2 3 10,348,395 - 10,355,208 (-) NCBI Rnor_6.0 3 5,568,321 - 5,575,136 (-) NCBI Rnor_5.0 3 10,930,061 - 10,936,876 (-) NCBI RGSC_v3.4 3 5,917,992 - 5,924,807 (-) RGD Celera 3 5,146,427 - 5,153,242 (-) RGD
Sequence:
GGAGCTTCGCCTGCCGCTCGAGGAGCTCGGGCGGATGCTTTAGCGCTGCGGTGGAGTCCAGCTGTATCTGACCATCTGTGCTGGCCATGCAGGAGCCCCTGCTAAGAGCCGAGGGACTGGACTATGAC ACCTTCCCCGAGGCGCCCGCGTCGCCTGAAGAGAAGGCACGGGCCGGGGCCTTGCAAAACAGAAGGGTGTTCCTGGCCACCTTCGCTGCCGTGCTGGGCAATTTCAGCTTTGGGTATGCCCTGGTCTA CACATCTCCAGTCATCCCTGCGCTGAAGCGCTCTTCTGACCCAGCACTACGCCTGGACAAAATCCAGGCATCCTGGTTTGGGTCCGTGTTCACCCTGGGTGCCGCCGCTGGGGGCCTCAGTGCTATGC TACTCAATGACCTCTTGGGCCGGAAGCTCAGCATCATGTTTTCCGCTGTCCCCTCGGCCATTGGCTATGCACTCATGGCTGGTGCCCGTGGCCTCTGGATGCTTCTGCTGGGGAGGATGCTGACAGGC TTTGCCGGGGGACTCACTGCTGCCTGCATCCCGGTGTACGTGTCTGAGATTGCACCCCCGGGTGTTCGCGGGGCCCTGGGGGCCACGCCGCAGCTCATGGCCGTGTTTGGATCCCTGTCTCTCTATGC CCTTGGCAAGTCTTCTGCTGCCTTGGCGATGGCTTGCCGTGGCCGGGGAGGGGCCTGTTCTGGTCATGATCCTGCTGCTTAGCTTCATGCCCAACTCGCCTCGCTTCCTACTGTCTAAGAGCCGGGAT GAGGAAGCACTGCAGGCGCTGATCTGGCTGCGAGCGGACTCTGAGGTCCACTGGGAGTTTGAGCAGATCCAGGACAACGTGCGGAGACAGAGTAGCCGAGTGTCGTGGGCGGAGGCCTGGGAGCCCCG TGTGTACCGGCCTATTCTCATTACAGTGCTGATGCGTTTTCTGCAGCAGCTGACAGGCATCACTCCCATCCTCGTGTACCTACAGACCATCTTCGACAGCACGTCCGTGGTGCTGCCCTCCCAGCAGG ATGCAGCTATAGTTGGTGCTGTGAGGCTCCTGTCTGTGCTGATTGCCGCTGTCACCATGGACCTGGCCGGCCGGAAAGTCCTGCTCTATGTGTCAGCATCCATTATGTTTGTCGCCAACCTGACGCTG GGGCTGTATGTCCAGCTTGTGCCAAGGACTCTGACCCCCAACAGCACTGTGGAGATCGTGACGCTTGGGGGCACGGAGCAGCCCCCAGCCGCGGCCTTCAACTATCTCACCCTGATACCCCTGCTGGC CACCATGCTCTTCATTATGGGCTATGCCATGGGCTGGGGGCCCATCACCTGGCTCCTCATGTCTGAGGTTCTGCCCCTGCGTGCCCGTGGTGTGGCCTCAGGGCTCTGCGTGCTGGTCAGCTGGCTCA CAGCCTTCGTCCTCACTAAGTACTTCCTGCTGGCAGTGAATGCCTTCGGCCTCCAGGTGCCTTTCTTCTTCTTCTCGGCCATCTGCCTGCTCAGCCTGCTCTTCACAGGCTGCTGTGTGCCTGAGACC AGGGGCCGCTCGCTGGAGCAGATCGAGGCCTTCTTCCACACTCGCAGGATGTCCTTCAGGCCCTAGTCAGGGGCTTGCCTGTAAGGGGCCAGGCCATGTGGGCCAGGCCTGTGCACACCTGCAGCCGG GAGCAGCAGCACCCCTGCCGTCAGCCACTGCACACTTCCACCTCGGACAGGCAGTTCACCAACTGTGGGCTGGTGGGCCCCAGCAGGCAGCCCGCAGTGCTGTAATACCTCAGCTGAGATCCGCAGGG GGGCAGGCAGCCCTGCCCCAGACTGAGCAAAGGCTGTACCCAAGAACAATGCTGTTGGGACCTCCGGTCTAGTTCCTCATTCCTACAAGGAACACTTCCCATGTAGGGCCATGTTGAGGACAGAAAAC AGGGATGGAGGTGGCAATGTGGCATTGTACAAGGACATTGTCACTTCCTTCTGATCAACTGGCCAGGGGGAGGACAGGGTCCTGTACCCTCAAGGGTCTGGGTACCTTGGGGAGCACTGGACCCAGTC CAACCTTGGATACCTCTAGTCTACAGACTGTTCACTGTTTTTCAAAATAAAGGAGCTGGGCCTACAGCCTCTGGGAGG
hide sequence
RefSeq Acc Id:
XM_063283472 ⟹ XP_063139542
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 30,746,484 - 30,753,282 (-) NCBI
RefSeq Acc Id:
XM_063283473 ⟹ XP_063139543
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 30,746,484 - 30,753,286 (-) NCBI
RefSeq Acc Id:
XM_063283474 ⟹ XP_063139544
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 30,746,484 - 30,753,282 (-) NCBI
RefSeq Acc Id:
XM_063283475 ⟹ XP_063139545
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 30,746,484 - 30,753,282 (-) NCBI
RefSeq Acc Id:
XM_063283476 ⟹ XP_063139546
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 30,746,484 - 30,753,261 (-) NCBI
RefSeq Acc Id:
NP_001100032 ⟸ NM_001106562
- Sequence:
MPLASLLLPWRWLAVAGEGPVLVMILLLSFMPNSPRFLLSKSRDEEALQALIWLRADSEVHWEFEQIQDNVRRQSSRVSWAEAWEPRVYRPILITVLMRFLQQLTGITPILVYLQTIFDSTSVVLPSQ QDAAIVGAVRLLSVLIAAVTMDLAGRKVLLYVSASIMFVANLTLGLYVQLVPRTLTPNSTVEIVTLGGTEQPPAAAFNYLTLIPLLATMLFIMGYAMGWGPITWLLMSEVLPLRARGVASGLCVLVSW LTAFVLTKYFLLAVNAFGLQVPFFFFSAICLLSLLFTGCCVPETRGRSLEQIEAFFHTRRMSFRP
hide sequence
Ensembl Acc Id:
ENSRNOP00000008034 ⟸ ENSRNOT00000008034
RefSeq Acc Id:
XP_063139543 ⟸ XM_063283473
- Peptide Label:
isoform X2
RefSeq Acc Id:
XP_063139545 ⟸ XM_063283475
- Peptide Label:
isoform X4
RefSeq Acc Id:
XP_063139544 ⟸ XM_063283474
- Peptide Label:
isoform X3
RefSeq Acc Id:
XP_063139542 ⟸ XM_063283472
- Peptide Label:
isoform X1
RefSeq Acc Id:
XP_063139546 ⟸ XM_063283476
- Peptide Label:
isoform X5
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2016-02-24
Slc2a6
solute carrier family 2 member 6
Slc2a6
solute carrier family 2 (facilitated glucose transporter), member 6
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-04-30
Slc2a6
solute carrier family 2 (facilitated glucose transporter), member 6
Slc2a6_predicted
solute carrier family 2 (facilitated glucose transporter), member 6 (predicted)
'predicted' is removed
2292626
APPROVED
2005-01-12
Slc2a6_predicted
solute carrier family 2 (facilitated glucose transporter), member 6 (predicted)
Symbol and Name status set to approved
70820
APPROVED